Table 4 Comparison of postoperative pathological upgrade risks based on endometrial sampling methods
From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
Endometrial sampling pathology | Upgrade on final pathology | Endometrial sampling method | P | |
|---|---|---|---|---|
D&C (n = 100) | Aspiration biopsy (n = 150) | |||
Hyperplasia without atypia | No | 49 (87.5) | 44 (71.0) | 0.028 |
Yes | 7 (12.5) | 18 (29.0) | ||
Atypical hyperplasia | No | 30 (68.2) | 51 (58.0) | 0.255 |
Yes | 14 (31.8) | 37 (42.0) | ||
Total | No | 79 (79.0) | 95 (63.3) | 0.008 |
Yes | 21 (21.0) | 55 (36.7) | ||